The Discounted Cash Flow (DCF) valuation of Neurocrine Biosciences Inc (NBIX) is 333.03 USD. With the latest stock price at 174.26 USD, the upside of Neurocrine Biosciences Inc based on DCF is 91.1%.
Based on the latest price of 174.26 USD and our DCF valuation, Neurocrine Biosciences Inc (NBIX) is a buy. buying NBIX stocks now will result in a potential gain of 91.1%.
| Range | Selected | |
| WACC / Discount Rate | 4.7% - 5.8% | 5.2% |
| Long-term Growth Rate | 3.0% - 4.4% | 3.7% |
| Fair Price | 187.10 - 1,951.79 | 333.03 |
| Upside | 7.4% - 1020.0% | 91.1% |